NR4A1 and hepatocellular carcinoma: In HCC, it has been shown that NR4A1 interacts with phosphoenolpyruvate carboxykinase (PEPCK1), the rate-limiting enzyme in gluconeogenesis, to increase gluconeogenesis and suppress glycolysis, resulting in ATP depletion and cell growth arrest (33).